vs

Side-by-side financial comparison of JBG SMITH Properties (JBGS) and MIMEDX GROUP, INC. (MDXG). Click either name above to swap in a different company.

JBG SMITH Properties is the larger business by last-quarter revenue ($127.6M vs $118.1M, roughly 1.1× MIMEDX GROUP, INC.). MIMEDX GROUP, INC. runs the higher net margin — 12.9% vs -18.1%, a 30.9% gap on every dollar of revenue. On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs 5.7%). Over the past eight quarters, MIMEDX GROUP, INC.'s revenue compounded faster (18.1% CAGR vs -2.9%).

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

JBGS vs MDXG — Head-to-Head

Bigger by revenue
JBGS
JBGS
1.1× larger
JBGS
$127.6M
$118.1M
MDXG
Growing faster (revenue YoY)
MDXG
MDXG
+21.4% gap
MDXG
27.1%
5.7%
JBGS
Higher net margin
MDXG
MDXG
30.9% more per $
MDXG
12.9%
-18.1%
JBGS
Faster 2-yr revenue CAGR
MDXG
MDXG
Annualised
MDXG
18.1%
-2.9%
JBGS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
JBGS
JBGS
MDXG
MDXG
Revenue
$127.6M
$118.1M
Net Profit
$-23.0M
$15.2M
Gross Margin
83.9%
Operating Margin
17.8%
Net Margin
-18.1%
12.9%
Revenue YoY
5.7%
27.1%
Net Profit YoY
57.1%
104.2%
EPS (diluted)
$-0.32
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBGS
JBGS
MDXG
MDXG
Q1 26
$127.6M
Q4 25
$127.6M
$118.1M
Q3 25
$123.9M
$113.7M
Q2 25
$126.5M
$98.6M
Q1 25
$120.7M
$88.2M
Q4 24
$130.8M
$92.9M
Q3 24
$136.0M
$84.1M
Q2 24
$135.3M
$87.2M
Net Profit
JBGS
JBGS
MDXG
MDXG
Q1 26
$-23.0M
Q4 25
$-45.5M
$15.2M
Q3 25
$-28.6M
$16.7M
Q2 25
$-19.2M
$9.6M
Q1 25
$-45.7M
$7.0M
Q4 24
$-59.9M
$7.4M
Q3 24
$-27.0M
$8.1M
Q2 24
$-24.4M
$17.6M
Gross Margin
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
83.9%
Q3 25
83.5%
Q2 25
81.1%
Q1 25
81.2%
Q4 24
81.8%
Q3 24
81.8%
Q2 24
83.0%
Operating Margin
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
-47.5%
17.8%
Q3 25
-27.5%
19.5%
Q2 25
-18.4%
12.5%
Q1 25
-44.7%
9.4%
Q4 24
-53.6%
11.9%
Q3 24
-22.4%
13.3%
Q2 24
-24.3%
26.9%
Net Margin
JBGS
JBGS
MDXG
MDXG
Q1 26
-18.1%
Q4 25
-35.7%
12.9%
Q3 25
-23.1%
14.7%
Q2 25
-15.2%
9.8%
Q1 25
-37.9%
8.0%
Q4 24
-45.8%
8.0%
Q3 24
-19.8%
9.6%
Q2 24
-18.0%
20.2%
EPS (diluted)
JBGS
JBGS
MDXG
MDXG
Q1 26
$-0.32
Q4 25
$-0.76
$0.10
Q3 25
$-0.48
$0.11
Q2 25
$-0.29
$0.06
Q1 25
$-0.56
$0.05
Q4 24
$-0.70
$0.05
Q3 24
$-0.32
$0.05
Q2 24
$-0.27
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBGS
JBGS
MDXG
MDXG
Cash + ST InvestmentsLiquidity on hand
$166.1M
Total DebtLower is stronger
$18.0M
Stockholders' EquityBook value
$256.5M
Total Assets
$4.3B
$342.7M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
$75.3M
$166.1M
Q3 25
$64.4M
$142.1M
Q2 25
$61.4M
$118.9M
Q1 25
$81.3M
$106.4M
Q4 24
$145.8M
$104.4M
Q3 24
$137.0M
$88.8M
Q2 24
$163.5M
$69.0M
Total Debt
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
$18.0M
Q3 25
Q2 25
Q1 25
Q4 24
$19.0M
Q3 24
Q2 24
Stockholders' Equity
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
$1.2B
$256.5M
Q3 25
$1.2B
$238.9M
Q2 25
$1.3B
$216.6M
Q1 25
$1.6B
$202.8M
Q4 24
$1.8B
$193.1M
Q3 24
$1.9B
$181.0M
Q2 24
$2.0B
$168.0M
Total Assets
JBGS
JBGS
MDXG
MDXG
Q1 26
$4.3B
Q4 25
$4.4B
$342.7M
Q3 25
$4.4B
$319.0M
Q2 25
$4.5B
$291.1M
Q1 25
$4.7B
$270.4M
Q4 24
$5.0B
$263.9M
Q3 24
$5.2B
$243.9M
Q2 24
$5.3B
$230.2M
Debt / Equity
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBGS
JBGS
MDXG
MDXG
Operating Cash FlowLast quarter
$25.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
$73.3M
$25.0M
Q3 25
$8.9M
$29.3M
Q2 25
$18.8M
$14.4M
Q1 25
$12.9M
$5.3M
Q4 24
$129.4M
$18.8M
Q3 24
$26.4M
$19.6M
Q2 24
$23.8M
$21.8M
Cash Conversion
JBGS
JBGS
MDXG
MDXG
Q1 26
Q4 25
1.64×
Q3 25
1.75×
Q2 25
1.50×
Q1 25
0.75×
Q4 24
2.53×
Q3 24
2.42×
Q2 24
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JBGS
JBGS

Property rental$105.9M83%
Third-party real estate services, including reimbursements$17.2M13%
Other revenue$4.5M4%

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

Related Comparisons